The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Glutathione metabolism in cancer progression and treatment resistance
Open accessAbstract
Glutathione (GSH) is the most abundant antioxidant found in living organisms and has multiple functions, most of which maintain cellular redox homeostasis. GSH preserves sufficient levels of cysteine and detoxifies xenobiotics while also conferring therapeutic resistance to cancer cells. However, GSH metabolism plays both beneficial and pathogenic roles in a variety of malignancies. It is crucial to the removal and detoxification of carcinogens, and alterations in this pathway can have a profound effect on cell survival. Excess GSH promotes tumor progression, where elevated levels correlate with increased metastasis. In this review, we discuss recent studies that focus on deciphering the role of GSH in tumor initiation and progression as well as mechanisms underlying how GSH imparts treatment resistance to growing cancers. Targeting GSH synthesis/utilization therefore represents a potential means of rendering tumor cells more susceptible to different treatment options such as chemotherapy and radiotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidants, antioxidants, and the degenerative diseases of aging.
Ames, B. N., Shigenaga, M. K., & Hagen, T. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7915 · Cited by 5,958
Ighodaro, O. M., & Akinloye, O. A. (2018) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2017.09.001 · Cited by 3,939
Glutathione Metabolism and Its Implications for Health
Wu, G., Lupton, J. R., Turner, N. D., Fang, Y.-Z., & Yang, S. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.3.489 · Cited by 3,842
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Ferroptosis: Death by Lipid Peroxidation
Yang, W. S., & Stockwell, B. R. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.014 · Cited by 3,088
Glutathione: overview of its protective roles, measurement, and biosynthesis
Forman, H. J., Zhang, H., & Rinna, A. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.006 · Cited by 2,636
Superoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling
Wang, Y., Branicky, R., Noë, A., & Hekimi, S. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201708007 · Cited by 2,182
Lu, S. C. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.09.008 · Cited by 2,166
Regulation of glutathione synthesis
Lu, S. C. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.05.005 · Cited by 2,116
Oxidative damage and mitochondrial decay in aging.
Shigenaga, M. K., Hagen, T. M., & Ames, B. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10771 · Cited by 2,055
Strategies of antioxidant defense
SIES, H. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18025.x · Cited by 1,976
REPAIR OF OXIDATIVE DAMAGE TO DNA: Enzymology and Biology
Demple, B., & Harrison, L. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.004411 · Cited by 1,495
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N., Kitami, T., Souza, A. L., Kafri, R., Kirschner, M. W., Clish, C. B., & Mootha, V. K. (2012) · Science · doi:10.1126/science.1218595 · Cited by 1,403
The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer
Kansanen, E., Kuosmanen, S. M., Leinonen, H., & Levonen, A.-L. (2013) · Redox Biology · doi:10.1016/j.redox.2012.10.001 · Cited by 1,313 · cited 4×
“Several mechanisms appear to be responsible for increased NRF2 activity in cancers: somatic mutations in KEAP1, CUL3, or NRF2; epigenetic silencing of KEAP; transcriptional NRF2 up-regulation through oncogene-dependent signaling and modification of KEAP1 by metabolic alterations (Kansanen et al., 2013); and cysteine m…”
BackgroundInfluentialThe emerging role of the Nrf2–Keap1 signaling pathway in cancer
Jaramillo, M. C., & Zhang, D. D. (2013) · Genes & Development · doi:10.1101/gad.225680.113 · Cited by 1,297
Glutathione Homeostasis and Functions: Potential Targets for Medical Interventions
Lushchak, V. I. (2012) · Journal of Amino Acids · doi:10.1155/2012/736837 · Cited by 1,266 · cited 1×
“Apart from the classical antioxidant role, GSH also has several organelle-specific functions discussed in detail by Lushchak (2012).”
BackgroundPersistent oxidative stress in cancer
Toyokuni, S., Okamoto, K., Yodoi, J., & Hiai, H. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01368-b · Cited by 1,219
Role of Glutathione in Cancer Progression and Chemoresistance
Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A. L., Pronzato, M. A., Marinari, U. M., & Domenicotti, C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/972913 · Cited by 1,208
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
Locasale, J. W., Grassian, A. R., Melman, T., Lyssiotis, C. A., Mattaini, K. R., Bass, A. J., Heffron, G., Metallo, C. M., Muranen, T., Sharfi, H., et al. (2011) · Nature Genetics · doi:10.1038/ng.890 · Cited by 1,120
Glutathione in Cancer Biology and Therapy
Estrela, J. M., Ortega, A., & Obrador, E. (2006) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500523878 · Cited by 1,041
Lewerenz, J., Hewett, S. J., Huang, Y., Lambros, M., Gout, P. W., Kalivas, P. W., Massie, A., Smolders, I., Methner, A., Pergande, M., et al. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4391 · Cited by 978
Reactive oxygen species and cancer paradox: To promote or to suppress?
Galadari, S., Rahman, A., Pallichankandy, S., & Thayyullathil, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.004 · Cited by 893
Antioxidants Accelerate Lung Cancer Progression in Mice
Sayin, V. I., Ibrahim, M. X., Larsson, E., Nilsson, J. A., Lindahl, P., & Bergo, M. O. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007653 · Cited by 867
Glutaminolysis: A Hallmark of Cancer Metabolism
Yang, L., Venneti, S., & Nagrath, D. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044546 · Cited by 859
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
Hakimi, A. A., Reznik, E., Lee, C.-H., Creighton, C. J., Brannon, A. R., Luna, A., Aksoy, B. A., Liu, E. M., Shen, R., Lee, W., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.004 · Cited by 798
NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis
Alvarez, S. W., Sviderskiy, V. O., Terzi, E. M., Papagiannakopoulos, T., Moreira, A. L., Adams, S., Sabatini, D. M., Birsoy, K., & Possemato, R. (2017) · Nature · doi:10.1038/nature24637 · Cited by 787
Small Molecule Modulators of Keap1‐ Nrf2‐ ARE Pathway as Potential Preventive and Therapeutic Agents
Magesh, S., Chen, Y., & Hu, L. (2012) · Medicinal Research Reviews · doi:10.1002/med.21257 · Cited by 760 · cited 2×
“Therefore, more thorough research needs to be performed to discover effective and highly selective inhibitors of NRF2 activity (Magesh et al., 2012).”
BackgroundBrusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
Ren, D., Villeneuve, N. F., Jiang, T., Wu, T., Lau, A., Toppin, H. A., & Zhang, D. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014275108 · Cited by 673
The Regulation of Hepatic Glutathione
Kaplowitz, N., Aw, T. Y., & Ookhtens, M. (1985) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.25.040185.003435 · Cited by 661
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
Romero, R., Sayin, V. I., Davidson, S. M., Bauer, M. R., Singh, S. X., LeBoeuf, S. E., Karakousi, T. R., Ellis, D. C., Bhutkar, A., Sánchez-Rivera, F. J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4407 · Cited by 652
Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine
Zhang, J., Pavlova, N. N., & Thompson, C. B. (2017) · The EMBO Journal · doi:10.15252/embj.201696151 · Cited by 651 · cited 4×
“Second, glutamine contributes to the maintenance of GSH in its reduced form by supporting the production of NAD PH through malic acid regulation (Zhang et al., 2017).”
BackgroundInfluentialGout, P., Buckley, A., Simms, C., & Bruchovsky, N. (2001) · Leukemia · doi:10.1038/sj.leu.2402238 · Cited by 640
Glutathione levels in human tumors
Gamcsik, M. P., Kasibhatla, M. S., Teeter, S. D., & Colvin, O. M. (2012) · Biomarkers · doi:10.3109/1354750x.2012.715672 · Cited by 600
S-adenosylmethionine in Liver Health, Injury, and Cancer
Lu, S. C., & Mato, J. M. (2012) · Physiological Reviews · doi:10.1152/physrev.00047.2011 · Cited by 554
Fructose-1,6-bisphosphatase opposes renal carcinoma progression
Li, B., Qiu, B., Lee, D. S. M., Walton, Z. E., Ochocki, J. D., Mathew, L. K., Mancuso, A., Gade, T. P. F., Keith, B., Nissim, I., et al. (2014) · Nature · doi:10.1038/nature13557 · Cited by 535
Self-citationThe KEAP1–NRF2 System in Cancer
Taguchi, K., & Yamamoto, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00085 · Cited by 527
Oxidative Stress and Antioxidants in Disease and Cancer: A Review
Gupta, R. K., Patel, A. K., Shah, N., Choudhary, A. K., Jha, U. K., Yadav, U. C., Gupta, P. K., & Pakuwal, U. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.11.4405 · Cited by 431
The x cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases
Lo, M., Wang, Y., & Gout, P. W. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21366 · Cited by 399
Wang, X. J., Hayes, J. D., Henderson, C. J., & Wolf, C. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709483104 · Cited by 309
Shin, C.-S., Mishra, P., Watrous, J. D., Carelli, V., D’Aurelio, M., Jain, M., & Chan, D. C. (2017) · Nature Communications · doi:10.1038/ncomms15074 · Cited by 305
DNA base modifications in chromatin of human cancerous tissues
Olinski, R., Zastawny, T., Budzbon, J., Skokowski, J., Zegarski, W., & Dizdaroglu, M. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81093-2 · Cited by 284
γ‐Glutamyl Transpeptidase in Glutathione Biosynthesis
Zhang, H., Jay Forman, H., & Choi, J. (2005) · Methods in Enzymology · doi:10.1016/s0076-6879(05)01028-1 · Cited by 260
The Enzymes of Glutathione Synthesis: γ‐Glutamylcysteine Synthetase
Griffith, O. W., & Mulcahy, R. T. (1999) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470123195.ch7 · Cited by 253
Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer
Lien, E. C., Lyssiotis, C. A., Juvekar, A., Hu, H., Asara, J. M., Cantley, L. C., & Toker, A. (2016) · Nature Cell Biology · doi:10.1038/ncb3341 · Cited by 249
Kredich, N. M. (2008) · EcoSal Plus · doi:10.1128/ecosalplus.3.6.1.11 · Cited by 244
Huang, Z.-Z., Chen, C., Zeng, Z., Yang, H., Oh, J., Chen, L., & C. Lu, S. (2001) · The FASEB Journal · doi:10.1096/fj.00-0445fje · Cited by 243
Corti, A., Franzini, M., Paolicchi, A., & Alfonso Pompella, C. (2010) · PubMed · Cited by 240
Sayin, V. I., LeBoeuf, S. E., Singh, S. X., Davidson, S. M., Biancur, D., Guzelhan, B. S., Alvarez, S. W., Wu, W. L., Karakousi, T. R., Zavitsanou, A. M., et al. (2017) · eLife · doi:10.7554/elife.28083 · Cited by 231
Human glutamate cysteine ligase gene regulation through the electrophile response element
Dickinson, D. A., Levonen, A.-L., Moellering, D. R., Arnold, E. K., Zhang, H., Darley-Usmar, V. M., & Forman, H. J. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.011 · Cited by 196
Hayes, J. D., Chowdhry, S., Dinkova-Kostova, A. T., & Sutherland, C. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150011 · Cited by 183
Yu, X., & Long, Y. C. (2016) · Scientific Reports · doi:10.1038/srep30033 · Cited by 170
Autophagy-Regulating microRNAs and Cancer
Gozuacik, D., Akkoc, Y., Ozturk, D. G., & Kocak, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00065 · Cited by 170
γ-Glutamyltransferase, redox regulation and cancer drug resistance
Pompella, A., Corti, A., Paolicchi, A., Giommarelli, C., & Zunino, F. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.04.004 · Cited by 167
Redox Regulation of γ-Glutamyl Transpeptidase
Zhang, H., & Forman, H. J. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0169tr · Cited by 166
Physiological and pathological aspects of GSH metabolism
Njälsson, R., & Norgren, S. (2005) · Acta Paediatrica · doi:10.1080/08035250410025285 · Cited by 160
Inborn errors in the metabolism of glutathione
Ristoff, E., & Larsson, A. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-16 · Cited by 141
Carretero, J., Obrador, E., Anasagasti, M. J., Martin, J. J., Vidal‐Vanaclocha, F., & Estrela, J. M. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006725226078 · Cited by 125
Tagde, A., Singh, H., Kang, M. H., & Reynolds, C. P. (2014) · Blood Cancer Journal · doi:10.1038/bcj.2014.45 · Cited by 124
The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders
Hybertson, B. M., Gao, B., & Doan, A. (2014) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s35078 · Cited by 116
Lu, M., Ji, J., Jiang, Y.-L., Chen, Z., Yuan, Z., You, Q., & Jiang, Z. (2016) · Scientific Reports · doi:10.1038/srep26585 · Cited by 114
Mutations in the glutathione synthetase gene cause 5–oxoprolinuria
Shi, Z.-Z., Habib, G. M., Rhead, W. J., Gahl, W. A., He, X., Sazer, S., & Lieberman, M. W. (1996) · Nature Genetics · doi:10.1038/ng1196-361 · Cited by 104
Villablanca, J. G., Volchenboum, S. L., Cho, H., Kang, M. H., Cohn, S. L., Anderson, C. P., Marachelian, A., Groshen, S. G., Tsao-Wei, D. D., Matthay, K. K., et al. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.25994 · Cited by 96
Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies
Conticello, C., Martinetti, D., Adamo, L., Buccheri, S., Giuffrida, R., Parrinello, N. L., Lombardo, L., Anastasi, G., Amato, G., Cavalli, M. M., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27482 · Cited by 86
Hofbauer, S. L., Stangl, K., de Martino, M., Lucca, I., Haitel, A., Shariat, S. F., & Klatte, T. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.450 · Cited by 74
Anderton, B. N., Camarda, R., Balakrishnan, S., Balakrishnan, A., Kohnz, R. A., Lim, L., Evason, K. J., Momčilović, O., Kruttwig, K., Huang, Q., et al. (2017) · EMBO Reports · doi:10.15252/embr.201643068 · Cited by 73
Andringa, K. K., Coleman, M. C., Aykin‐Burns, N., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3462 · Cited by 72
Human γ-Glutamyl Transpeptidase 1
Terzyan, S. S., Burgett, A. W. G., Heroux, A., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.659680 · Cited by 62
Metabolic regulation of T cell differentiation and function
Park, B. V., & Pan, F. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.07.027 · Cited by 58
Increased cystine uptake capability associated with malignant progression of Nb2 lymphoma cells
Gout, P., Kang, Y. J., Buckley, D., Bruchovsky, N., & Buckley, A. (1997) · Leukemia · doi:10.1038/sj.leu.2400739 · Cited by 53
Kim, A. D., Zhang, R., Han, X., Kang, K. A., Piao, M. J., Maeng, Y. H., Chang, W. Y., & Hyun, J. W. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3902 · Cited by 53
Zhang, Z., Lee, E. E., Sudderth, J., Yue, Y., Zia, A. N., Glass, D. A., DeBerardinis, R. J., & Wang, R. C. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.c116.748848 · Cited by 50
Alanazi, A. M., Mostafa, G. A. E., & Al‐Badr, A. A. (2015) · Profiles of drug substances, excipients, and related methodology · doi:10.1016/bs.podrm.2015.02.001 · Cited by 46
Ke, H., Lin, J. M., Ye, Y., Wu, W., Lin, H., Wei, H., Huang, M., Chang, D. W., Dinney, C. P., & Wu, X. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4431-5 · Cited by 43
Altered glutamate cysteine ligase expression and activity in renal cell carcinoma
Li, M., Zhang, Z., Yuan, J., Zhang, Y., & Jin, X. (2014) · Biomedical Reports · doi:10.3892/br.2014.359 · Cited by 35
Cited by
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Bukowski, K., Kciuk, M., & Kontek, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093233 · Cited by 1,757
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Aggarwal, V., Tuli, H., Varol, A., Thakral, F., Yerer, M., Sak, K., Varol, M., Jain, A., Khan, M., & Sethi, G. (2019) · Biomolecules · doi:10.3390/biom9110735 · Cited by 1,221
Niu, B., Liao, K., Zhou, Y., Wen, T., Quan, G., Pan, X., & Wu, C. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121110 · Cited by 1,168
Role of Glutathione in Cancer: From Mechanisms to Therapies
Kennedy, L., Sandhu, J. K., Harper, M.-E., & Cuperlovic-Culf, M. (2020) · Biomolecules · doi:10.3390/biom10101429 · Cited by 880
Engineering nanomedicine for glutathione depletion-augmented cancer therapy
Xiong, Y., Xiao, C., Li, Z., & Yang, X. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00718h · Cited by 692
Metadata
- Authors
- Bansal, A., & Simon, M. C.
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2018-06-18
- Volume
- 217
- Issue
- 7
- Pages
- 2291-2298
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2809388839
- Cited by
- 1,233
- References
- 75
- FWCI
- 31.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.